Company Updates
8i Unveils First Volumetric VR Project Featuring Real Human Actors at Sundance
22nd January 2016, Medium By Linc Gasking Throughout history, storytellers have always strived to create realistic depictions of their fellow man or woman. Cavemen scratched stick figures into walls; Renaissance painters spent months, if not years, capturing the likenesses of their muses and benefactors; and early photographers worked to master exposure times and shutter speeds. […]
Tesserent Cyber Security IPO Closes Early and Oversubscribed
Maximum of $7m raised Trading on ASX expected to commence shortly Tesserent Limited has closed its initial public offering (IPO) oversubscribed, successfully raising the maximum amount of $7 million. The issue closed on Wednesday 20 January 2016 at AEST 5pm, approximately two weeks ahead of its scheduled close of 5 February. The company’s shares are […]
APN Convenience Retail Property Fund Update
21st January 2016, ASX Announcement In light of Monday’s announcement by Woolworths Limited in respect of the Masters business, APN is providing an update to the market on the APN Convenience Retail Property Fund (the Fund). As previously advised to the market, the Fund is currently being established and includes a property agreed to be […]
Big Achievements for Proteomics in December Quarter 2015 – Full Report Available
21st January 2016, ASX Announcement Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to provide the following update on its business activities for the three month period from 31 December 2015. Highlights: PromarkerD Commercialisation progress: Company has now established active, ongoing commercialisation dialogue in key global markets – USA, […]
DJ Carmichael Research Report on Crowd Mobile
21st January 2016, ASX Announcement Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (Crowd Mobile or the Company) is pleased to announce the release and publication of a research note by DJ Carmichael Limited on the Company (Research Note). The Research Note is available for review on Crowd Mobile’s website, which you can view by […]
Prescient Therapeutics Presents at NobleCon12
21st January 2016, ASX Announcement Clinical stage oncology company Prescient Therapeutics Limited (ASX:PTX), today announced that Director, Mr Steven Yatomi-Clarke, has presented at the NonbleCon12 – Noble Financial Capital Markets’ Twelfth Annual Investor Conference at Club Med in Sandiper Bay, Florida. To view a recording and a copy of the presentation materials, please click here.
Big Un Limited December 2015 Quarter Revenues Above Guidance
21st January 2016, ASX Announcement Highlights: Big Un Limited to report continued strong growth for the quarter ended 31 December 2015 with cash receipts of $650,405 (September 2015: $406,582) well above the Company’s previously announced guidance of $600,00 60% increase on the September quarter represents another period of robust growth with an encouraging contribution from […]
D’Arcy Polychrome Seeks Further Capital to Expand Sales into US After Securing Over $650,000
D’Arcy Polychrome Limited (“DPL”) seeks NZD2 million of new equity investment to fund the commercialisation of drikolor™, a proprietary and high margin colouring system for paint and concrete. drikolor delivers colour through dry granulated pigments that rapidly mixed into base paints and concrete. Please click here for a short video introduction. The company’s technology means drikolor can […]
OncoSil Appoints Independent Non-Executive Director
21st January 2016, ASX Announcement OncoSil Medical Limited (ASX: OSL) is pleased to announce the appointment today of Dr Chris Roberts as an Independent Non-Executive Director of the Company, with immediate effect. Dr Robert is a highly experienced director and senior executive with 40 years’ experience in the medical innovation space. During this time he has […]
Backed By Leading Investment Groups and Family Offices
